Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Holding(s) in Company

6th Feb 2009 17:15

RNS Number : 9697M
Biofutures International plc
06 February 2009
 



For filings with the FSA include the annex

For filings with issuer exclude the annex 

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

BIOFUTURES INTERNATIONAL PLC

2. Reason for notification (yes/no)

An acquisition or disposal of voting rights

YES

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 

An event changing the breakdown of voting rights

Other (please specify):______________

3. Full name of person(s) subject to notification obligation:

RELIGARE HICHENS, HARRISON PLC

4. Full name of shareholder(s) (if different from 3):

5. Date of transaction (and date on which the threshold is crossed or reached if different):

5 FEBRUARY 2009

6. Date on which issuer notified:

6 FEBRUARY 2009

7. Threshold(s) that is/are crossed or reached:

8%

8: Notified Details

A: Voting rights attached to shares

Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of voting rights

Percentage of voting rights

Direct

Indirect

Direct

Indirect

ORDINARY SHARES OF 1P

GB00B12B4T47

NIL

NIL

12,712,177

12,712,177

NIL

8.42%

NIL

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

Total (A+B)

Number of voting rights

Percentage of voting rights

12,712,177

8.42%

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

Proxy Voting:

10. Name of proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

14 Contact name:

JOHN EDEN

15. Contact telephone number:

(020) 7382 7790

For notes on how to complete form TR-1 please see the FSA website. 

For further information please contact:

Julie Pomeroy, Finance Director, Biofutures International plc 0117 920 0092

Derek Crowhurst, Blomfield Corporate Finance Limited 0207 489 4500

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLTFMRTMMBMBTL

Related Shares:

Graphene Nanochem
FTSE 100 Latest
Value8,275.66
Change0.00